Navigation Links
Folic acid, B vitamins do not appear to affect cancer risk
Date:11/4/2008

l invasive cancer, breast cancer, or any cancer death." There were no differences according to current use of multivitamin supplements, intakes of total folate, vitamin B6, and vitamin B12, or history of cancer at baseline. Lack of effect for total invasive cancer did not vary over time.

Age significantly modified the effect of combined B vitamin treatment on risk of total invasive cancer and breast cancer. A significantly reduced risk was observed for total invasive cancer and breast cancer among women age 65 years or older at study entry, but no reductions in risk were observed among younger women (40-54 years or 55-64 years).

"If the finding is real and substantiated, the results may have public health significance because the incidence rates of cancer are high in elderly persons. The finding is biologically plausible because elderly individuals have increased requirements for these B vitamins," the authors write.

"In conclusion, treatment with combined folic acid, vitamin B6, and vitamin B12 provided neither beneficial nor harmful effects on overall risk of total cancer, breast cancer, or deaths from cancer among women at high risk for CVD."


'/>"/>

Contact: Lori Shanks
617-534-1604
JAMA and Archives Journals
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Folic Acid and Other B Vitamins Wont Help Prevent Cancer
2. Folic Acid Doesnt Help the Heart
3. Folic Acid in the Food Supply Reduces Birth Defects, but May Cause Extra Cancers, Reports the Harvard Womens Health Watch
4. Folic Acid May Help Prevent Premature Birth
5. Womens Folic Acid Levels Improving
6. Meijer Pharmacies to Offer Free Pre-Natal Vitamins
7. Expectant Moms Offered Free Prenatal Prescription Vitamins at D-FW Area Carnival, Minyard and Sackn Save Stores
8. Nature Made(R) Changes the Way America Takes Vitamins
9. Flavor and Vitamins on the Go
10. New Renuva Daily Balance Spray Is Designed to Be the Easiest and Best Way to Take Daily Vitamins and Minerals
11. Finding the Right Home for Your Vitamins and Other Supplements
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2009)... the Clinical Workflow , ... ... using point-of-care resources from EBSCO Publishing ... a new agreement which gives healthcare providers integrated access ... relevant and current information and improved quality care. This ...
(Date:12/7/2009)... calculator. Answer simple questions about income and watch the tax refund grow. ... ... using the free tax calculator. , , , , ,The calculator is so ... about how much the return will be or how much tax is due. ... right now with a few clicks of the mouse. , , ,Online ...
(Date:12/7/2009)... -- Cell Therapeutics, Inc. ("CTI") (Nasdaq and MTA: ... St. George,s Hospital, University of London during a ... ("ASH") Annual Meeting updated results from the pivotal ... pixantrone (the "PIX 301 EXTEND trial") in relapsed ... who have failed 2 or more prior therapies. ...
(Date:12/7/2009)... to reverse some of the damage to their lungs ... cigarettes, according to research out of the University of ... published in the December 15 issue of the American ... Care Medicine . , "We found that exposure to ... epithelium, or lining, of the airways in the lung. ...
(Date:12/6/2009)... to avoid oysters harvested from San Antonio Bay ... U.S. Food and Drug Administration is advising consumers to ... on or after Nov. 16 due to reports of ... harvested from this area, which is located on the ... ) ,, The FDA, along with the Centers ...
Breaking Medicine News(10 mins):Health News:EBSCO Publishing and Zynx Health Expand Partnership for Integrated Access to Evidence-Based Content 2Health News:EBSCO Publishing and Zynx Health Expand Partnership for Integrated Access to Evidence-Based Content 3Health News:2009 Free Tax Return Calculator 2Health News:Pixantrone Produces 250% Relative Improvement in 1 Year Progression Free Survival for Patients With Relapsed/Refractory, Aggressive Non-Hodgkin's Lymphoma Across All Measured Risk Factors - Updated Follow-Up Data 2Health News:Pixantrone Produces 250% Relative Improvement in 1 Year Progression Free Survival for Patients With Relapsed/Refractory, Aggressive Non-Hodgkin's Lymphoma Across All Measured Risk Factors - Updated Follow-Up Data 3Health News:Pixantrone Produces 250% Relative Improvement in 1 Year Progression Free Survival for Patients With Relapsed/Refractory, Aggressive Non-Hodgkin's Lymphoma Across All Measured Risk Factors - Updated Follow-Up Data 4Health News:Pixantrone Produces 250% Relative Improvement in 1 Year Progression Free Survival for Patients With Relapsed/Refractory, Aggressive Non-Hodgkin's Lymphoma Across All Measured Risk Factors - Updated Follow-Up Data 5Health News:Quitting smoking can reverse asthma-inducing changes in lungs 2Health News:FDA, CDC, and States Investigating Norovirus Illnesses Linked to Oysters 2
... Three have died from rare brain infection while taking ... 19 (HealthDay News) -- U.S. health officials issued a ... after confirming that three people using the medication have ... of a rare brain infection called progressive multifocal leukoencephalopathy ...
... SAN DIEGO, Feb. 19 A new analysis from ... Conference (ISC) in San Diego, California describes details of ... risk factors. This data adds to the primary ... (rosuvastatin calcium) 20mg significantly reduced the risk of stroke ...
... A new study released today found blacks remain ... an important intervention for reducing pain and improving physical ... also found total knee replacements are increasing substantially in ... research underscores the need for healthcare providers and people ...
... a third since 1997, study shows , , THURSDAY, Feb. 19 ... uninsured Americans rose by 34 percent, from 1.7 million to ... is more than double the 14 percent rise in overall ... report by the Agency for Healthcare Research and Quality. , ...
... among the who,s who of asbestos litigators to assemble ... litigation trends and review what transpired in 2008.Shepard Hoffman, ... will be among a panel of litigators discussing new ... & Greenstone and Robert Thackston of Hawkins, Parnell & ...
... Inc. (Nasdaq: NYER ) reported results for the ... the second quarter of fiscal 2009 increased $1.8 million or ... the comparable quarter in the prior year. The ... four new pharmacies over the past 12 months. Revenues ...
Other Medicine News:Health News:FDA Warns Users on Psoriasis Drug 2Health News:FDA Warns Users on Psoriasis Drug 3Health News:CRESTOR Cuts Risk of Stroke by Nearly Half in JUPITER Study 2Health News:CRESTOR Cuts Risk of Stroke by Nearly Half in JUPITER Study 3Health News:CRESTOR Cuts Risk of Stroke by Nearly Half in JUPITER Study 4Health News:New study finds blacks still lag in obtaining total knee replacements for arthritis 2Health News:New study finds blacks still lag in obtaining total knee replacements for arthritis 3Health News:Uninsured Hospital Stays On the Rise 2Health News:Dallas Attorneys Featured at Major Asbestos Litigation Event 2Health News:Nyer Medical Group, Inc. Reports Revenues of $19.0 Million for the Quarter Ended December 31, 2008 2Health News:Nyer Medical Group, Inc. Reports Revenues of $19.0 Million for the Quarter Ended December 31, 2008 3Health News:Nyer Medical Group, Inc. Reports Revenues of $19.0 Million for the Quarter Ended December 31, 2008 4Health News:Nyer Medical Group, Inc. Reports Revenues of $19.0 Million for the Quarter Ended December 31, 2008 5
(Date:12/4/2009)... Neb., Dec. 4 Amber Pharmacy announced today that ... Care, Inc. (ACHC) for specialized pharmacy services. For nearly ... programs and services to meet the unique needs of ... providers of services to transplant programs. They work with ...
(Date:12/4/2009)... Imaging, LLC, an independent provider of CT, MRI ... and healthcare providers, is excited to announce it ... Health Care, a nationally-recognized, prestigious gold seal of ... Shared Imaging accreditation is system-wide for its mobile ...
(Date:12/4/2009)... in tin cans and car trunks ,, WASHINGTON, ... the Senate to defeat the Dorgan Importation plan encompassed in ... amendment is poised to open our borders, allowing our safe, ... be endangered. We could soon be getting drugs that ...
Breaking Medicine Technology:Amber Pharmacy Earns Accreditation From ACHC 2Shared Imaging Earns The Joint Commission's Accreditation for Ambulatory Health Care 2RetireSafe Urges Senate to Defeat Senate Amendment 2793 -- Says Senator Dorgan's Drug Importation Plan Puts Seniors at Risk 2Providence Service Corporation to Present at the Baird 2009 Healthcare Conference on September 9 55994 1Providence Service Corporation to Present at the Baird 2009 Healthcare Conference on September 9 55994 2Accumetrics Inc Forms Partnership With Grifols as Its Distributor in Spain Portugal and Chile 55991 1Accumetrics Inc Forms Partnership With Grifols as Its Distributor in Spain Portugal and Chile 55991 2Accumetrics Inc Forms Partnership With Grifols as Its Distributor in Spain Portugal and Chile 55991 3Poniard Pharmaceuticals To Present at Three Upcoming Investor Conferences in September 13798 1Poniard Pharmaceuticals To Present at Three Upcoming Investor Conferences in September 13798 2
... Nov. 9 This week, Dr. Fouad,Bachour, ... Hennepin County,Medical Center, presented results of a ... http://www.sessionsdailynews.com/tuesday.pdf ) meeting in Orlando showing,that alerting ... a heart attack,patient arrives improves door-to-balloon times ...
... of Rheumatology Annual Meeting -, BOSTON, Nov. ... today announced that cumulative five-year data from an,open-label ... the,long-term efficacy and safety of ORENCIA(R) (abatacept) in ... response to methotrexate,(MTX). The data show that, in ...
Other Medicine Technology:Study Confirms That New Protocol Shortens the Time It Takes to Open Blocked Arteries for Heart Attack Patients 2Five-Year Data Demonstrate Long-Term Efficacy and Safety with ORENCIA(R) (abatacept) in Adults with Rheumatoid Arthritis Who had an Inadequate Response to Methotrexate 2Five-Year Data Demonstrate Long-Term Efficacy and Safety with ORENCIA(R) (abatacept) in Adults with Rheumatoid Arthritis Who had an Inadequate Response to Methotrexate 3Five-Year Data Demonstrate Long-Term Efficacy and Safety with ORENCIA(R) (abatacept) in Adults with Rheumatoid Arthritis Who had an Inadequate Response to Methotrexate 4Five-Year Data Demonstrate Long-Term Efficacy and Safety with ORENCIA(R) (abatacept) in Adults with Rheumatoid Arthritis Who had an Inadequate Response to Methotrexate 5Five-Year Data Demonstrate Long-Term Efficacy and Safety with ORENCIA(R) (abatacept) in Adults with Rheumatoid Arthritis Who had an Inadequate Response to Methotrexate 6
For proper plug sizing....
To prevent retraction of the conjunctival cul-de-sacs without touching the cornea....
For Frontalis Suspension in patients with significant ptosis and poor levator function....
... received the FDA approval to market its ... enucleation procedures in the United States. The ... non-brittle biomaterial alumina (AL2, O3), and features ... in size. The vicryl (polyglactin 910) mesh ...
Medicine Products: